Pharmacological consequences of long-term morphine treatment in patients with cancer and chronic non-malignant pain
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
In patients with pain of malignant origin morphine may be administered in high and often increasing doses during extended periods of time. In patients with chronic pain of non-malignant origin morphine may be an important remedy, and in these cases the goal is to keep the morphine dose stable. The pharmacokinetic as well as the pharmacodynamic consequences of long-term morphine treatment with special reference to the two most important metabolites of morphine morphine-6-glucuronide (M-6-G) and morphine-3-glucuronide (M-3-G) remain to be settled.
Originalsprog | Engelsk |
---|---|
Tidsskrift | European Journal of Pain |
Vol/bind | 8 |
Udgave nummer | 3 |
Sider (fra-til) | 263-71 |
Antal sider | 9 |
ISSN | 1090-3801 |
DOI | |
Status | Udgivet - jun. 2004 |
Links
- https://www.sciencedirect.com/science/article/pii/S1090380103001265
Forlagets udgivne version
ID: 46098448